Mollie Rene DeShazo MD
Urologic Oncologist, Division of Hematology/Oncology, University of Alabama at Birmingham
Join to view full profile
2500 North Pavilion1802 2nd Avenue SouthBirmingham, AL 35294
Phone+1 205-801-9034
Dr. DeShazo is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Mollie DeShazo, MD is a specialist in Oncology based in Birmingham, AL. Her comprehensive educational background consists of a Fellowship and Residency completed at the University of Alabama Medical Center, where she also completed her medical degree. She currently works as a Physician at UAB in the Division of Hematology Oncology as a urologic oncologist. Dr. DeShazo possesses expertise in a number of areas, neuroendocrine tumors and GU malignancies. Over the years, she has contributed to numerous medical publications, with her work getting cited several times in other publications. She has received multiple teaching awards for her work with medical students and fellows.
Education & Training
University of Alabama Hospital (Birmingham)Fellowship, Hematology and Medical Oncology, 2003 - 2006- University of Alabama Hospital (Birmingham)Residency, Internal Medicine, 2000 - 2003
University of Alabama School of MedicineClass of 2000
Certifications & Licensure
AL State Medical License 2002 - 2026
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification HealthSentry, Cerner Corporation, 2012, 2014-2017
- CMS Meaningful Use Stage 2 Certification PowerChart (Clinical), Cerner Corporation, 2012, 2014-2017
- CMS Meaningful Use Stage 2 Certification HealtheLife and PowerChart, Cerner Corporation, 2012, 2014-2017
Publications & Presentations
PubMed
- Pertuzumab and Trastuzumab in Patients With-Altered Urothelial or Ovary/Fallopian Tube Cancer: Results From the Targeted Agent and Profiling Utilization Registry Study.John K Chan, Michael Rothe, Elizabeth Garrett-Mayer, Evan Pisick, Pooja Ghatalia
JCO Precision Oncology. 2026-04-01 - 7 citationsClinical Results and Biomarker Analyses of Axitinib and TRC105 versus Axitinib Alone in Patients with Advanced or Metastatic Renal Cell Carcinoma (TRAXAR)Toni K. Choueiri, Yousef Zakharia, Sumanta K. Pal, Judit Kocsis, Russell K. Pachynski
The Oncologist. 2021-07-01 - 9 citationsPatient Demographics and Referral Patterns for [F-18]Fluciclovine-PET Imaging at a Tertiary Academic Medical Center.Samuel J. Galgano, Carli E Calderone, Andrew M. McDonald, Jeffrey W. Nix, Mollie deShazo
Journal of the American College of Radiology. 2019-03-01
Journal Articles
- Treatment of non-small cell lung cancer in the older patient.Ganti, AK, deShazo, M, Weir III AB, Hurria A, JNCCN, 2012
- Management of squamous cell carcinoma of the head and neck in the elderly: Review and recommendations.Weir A, Ganti AK, deShazo M, Samant S, Hurria A., Journal of Geriatric Oncology, 2012
- Intensive anti-inflammatory therapy with dexamethasone in patients with non-small cell lung cancer: effect on chemotherapy toxicity and efficacy.Leggas M, Kuo K, Robert F, Cloud G, deShazo M, Zhang R, Cancer Chemotherapy and Pharmacology, 2008
Press Mentions
Cancer Patients at Increased Risk for Severe Flu ComplicationsNovember 25th, 2013
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
